Search

Mutations in the BRCA1 and BRCA2 genes cause hereditary breast-ovarian cancer syndrome, with a greatly increased risk of certain cancers (particularly breast cancer) in affected individuals. What is l

A woman has filed a complaint with the US Equal Opportunity Commission and Connecticut Commission on Human Rights and Opportunities against her former employers, claiming genetic discrimination after

In the latest legal reversal, a US judge has ruled that two patents held by Myriad Genetics for the diagnosis of mutations in the BRCA1 and BRCA2 genes associated with inherited predisposition to brea

Cancer arises when a series of mutations accumulate that act together to block normal DNA repair (correction of spontaneous mutations) and deregulate normal control over cellular proliferation. A pape

The long standing gene patents held by Myriad Genetics, for diagnosing a predisposition to breast and ovarian cancer using BRCA1 and BRCA2  testing, are now facing a legal challenge that could th

The UK Clinical Molecular Genetics Society (CMGS) has recently completed the latest annual audit of National Health Service genetics laboratories. The 2007-8 figures show a significant rise in the tot

The UK media have widely reported on the birth of the first baby following screening by preimplantation genetic diagnosis (PGD) to identify embryos carrying an inherited BRCA gene mutation. The Human

The European Patent Office (EPO) has upheld an appeal by company Myriad Genetics with respect to European patent No. 699754, which relates to a "Method for diagnosing a predisposition for breast

A team from the Gynaecological Cancer Research Centre at the UCL Institute for Women’s Health in London has launched a new project to identify individuals at increased genetic risk of developing

A paper in the British Journal of Cancer presents evidence that male carriers of mutations in the BRCA1 or BRCA2 genes (associated with hereditary breast-ovarian cancer syndrome) are not only at five-